MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Clonazepam"

  • 2023 International Congress

    Holmes Tremor and Dystonia as Manifestation of Benedikt Syndrome in HIV-Related Cerebral Toxoplasmosis : A Case Report

    NER. Raisa, AC. Pratiwi, SB. Rianawati, BDM. Munir (Malang, Indonesia)

    Objective: To present movement disorder symptoms of Holmes tremor and dystonia as part of Benedikt Syndrome in a patient diagnosed with HIV-Related Cerebral Toxoplasmosis Background:…
  • 2023 International Congress

    Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model

    S. Polet, R. Lambrechts, M. de Koning-Tijssen, O. Sibon, T. de Koning, J. Gorter (Groningen, Netherlands)

    Objective: To determine the effect of conventional anti-epileptic drugs in a North Sea Progressive Myoclonus Epilepsy (NS-PME) Drosophila model. Background: In 2011, Corbett et al.…
  • 2023 International Congress

    Myoclonus Phenomenology and its Response to Antiepileptic drugs in Patients with Sub acute Sclerosing Pan encephalitis

    S. Pandey, K. Db, R. Garg, H. Malhotra, A. Jain, S. Kumar (LUCKNOW, India)

    Objective: To assess myoclonus phenomenology and its response to antiepileptic drugs in patients with SSPE. Background: Myoclonus is one of the characteristic features of Sub…
  • 2022 International Congress

    Myoclonus – encephalopathy induced by ifosfamide in a Non-Hodgkin lymphoma patient

    D. Rebolledo García (Mexico City, Mexico)

    Objective: Describe a clinical vignette about toxicity by ifosfamide in a man with follicular lymphoma (FL) that presented myoclonus and altered consciousness six hours after…
  • 2022 International Congress

    A CASE OF MEIGE SYNDROME IN INDONESIA TREATED WITH HALOPERIDOL

    K. Kandhisa, EA. Albertin, MG. Gaharu (Jakarta, Indonesia)

    Objective: To give a brief picture about the challenge of diagnosing and treating patients with Meige syndrome and to report a case of Meige syndrome…
  • 2022 International Congress

    Edentulous stereotypy: Common lacunae in the identification of an old malady

    D. Desai, S. Desai (Anand, India)

    Objective: To characterize the common errors or pitfalls in the recognition of edentulous stereotypy Background: Edentulous stereotypy is a well-characterized abnormal movement of the jaw…
  • MDS Virtual Congress 2021

    Potential drug-drug interactions in hospitalized patients with Parkinson’s disease from tertiary center in Serbia

    D. Aleksic, S. Stefanovic, M. Milosavljevic, J. Milosavljevic, S. Jankovic (Kragujevac, Serbia)

    Objective: The aim of this study was to identify predictors of potential drug-drug interactions in patients suffering from Parkinson’s disease.The aim of this study was…
  • MDS Virtual Congress 2020

    Writer’s cramp: A focal dystonia exacerbated by psychological symptoms

    A. Verghese (Georgetown, Malaysia)

    Objective: Here we retrospectively analysed nineteen patients followed up in our centre, the Neurology Unit of the Penang General Hospital, for writer’s cramp from the…
  • 2019 International Congress

    Potential treatment considerations for refractory REM behavior disorder

    J. Nguyen, K. Papesh (Las Vegas, NV, USA)

    Objective: A meta-analysis of alternative treatment therapies for refractory REM behavior disorder. Background: Parkinson’s disease is a neurodegenerative syndrome that affects motor and non-motor functions.…
  • 2019 International Congress

    Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome

    S. Raju, K. Vyas (Bangalore, India)

    Objective: To report a case of clonazepam induced withdrawal emergent dyskinesia. Background: Withdrawal emergent syndrome was first described in 1973 when it was noticed that…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley